Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Aug 21, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
General Notices
- Notice of Information: NIAAA Preclinical Medication Efficacy Testing Program
National Institute on Alcohol Abuse and Alcoholism - NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-017, "Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed)"
National Heart, Lung, and Blood Institute - NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-015, "Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)"
National Heart, Lung, and Blood Institute - Notice of Correction to the Companion Program Announcement Cited in PA-19-118, Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
National Institutes of Health
Notice of Changes to Funding Opportunities
- Notice of Change to Other Attachments in RFA-AI-19-045 "HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)"
National Institute of Allergy and Infectious Diseases
- Notice to Extend PAR-18-113, Center of Excellence for Research on Complementary and Integrative Health (P01, Clinical Trial Optional)
National Center for Complementary and Integrative Health
- Notice of NCCIH's Withdrawal from Participation in PAR-18-494, "Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)"
National Center for Complementary and Integrative Health
- Notice of Expiration for RFA-OD-19-019 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"
Office of Disease Prevention
Notices of Intent to Publish
- Notice of Intent to Publish Reissuance of RFA-OD-19-019 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Notices of Special Interest
- Notice of Special Interest: Selective Cell and Network Vulnerability in Aging and Alzheimers Disease
National Institute on Aging
- Notice of Special Interest (NOSI): Public Health Research on Cannabis
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health (Parent R01 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
Funding Opportunities
- Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
- Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
National Cancer Institute
- Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)
National Institute of General Medical Sciences
- Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior (R01 Clinical Trial Optional)
National Institute of Mental Health
- NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
National Institute on Drug Abuse
- Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
- Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
- Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
National Cancer Institute
- NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
National Cancer Institute
- Research Education: Short Courses on Alzheimer's Disease and Related Dementias for the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)
National Institute on Aging
- Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu